Bank of New York Mellon’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.34M Sell
780,627
-137,583
-15% -$237K ﹤0.01% 2939
2025
Q1
$3.06M Buy
918,210
+52,376
+6% +$174K ﹤0.01% 2455
2024
Q4
$6.41M Buy
865,834
+23,865
+3% +$177K ﹤0.01% 2151
2024
Q3
$7.91M Sell
841,969
-192,791
-19% -$1.81M ﹤0.01% 2060
2024
Q2
$8.3M Buy
1,034,760
+200,536
+24% +$1.61M ﹤0.01% 2059
2024
Q1
$12.4M Sell
834,224
-15,981
-2% -$237K ﹤0.01% 1853
2023
Q4
$6.91M Sell
850,205
-3,739
-0.4% -$30.4K ﹤0.01% 2207
2023
Q3
$3.89M Buy
853,944
+56,160
+7% +$256K ﹤0.01% 2444
2023
Q2
$5.62M Buy
797,784
+209,779
+36% +$1.48M ﹤0.01% 2254
2023
Q1
$3.59M Sell
588,005
-11,848
-2% -$72.4K ﹤0.01% 2477
2022
Q4
$3.83M Sell
599,853
-111,457
-16% -$712K ﹤0.01% 2490
2022
Q3
$6.81M Sell
711,310
-155,446
-18% -$1.49M ﹤0.01% 2126
2022
Q2
$9.57M Sell
866,756
-905,251
-51% -$9.99M ﹤0.01% 1964
2022
Q1
$29.5M Buy
1,772,007
+104,913
+6% +$1.75M 0.01% 1431
2021
Q4
$31.8M Sell
1,667,094
-51,839
-3% -$990K 0.01% 1443
2021
Q3
$42.4M Sell
1,718,933
-20,842
-1% -$514K 0.01% 1245
2021
Q2
$45.3M Buy
1,739,775
+231,203
+15% +$6.02M 0.01% 1208
2021
Q1
$47.8M Buy
1,508,572
+20,571
+1% +$651K 0.01% 1139
2020
Q4
$69M Buy
1,488,001
+417,070
+39% +$19.4M 0.02% 842
2020
Q3
$35.3M Buy
1,070,931
+20,388
+2% +$671K 0.01% 1111
2020
Q2
$28.8M Buy
1,050,543
+166,468
+19% +$4.57M 0.01% 1202
2020
Q1
$26.5M Buy
884,075
+314,369
+55% +$9.41M 0.01% 1118
2019
Q4
$15.8M Buy
569,706
+38,208
+7% +$1.06M ﹤0.01% 1709
2019
Q3
$9.67M Sell
531,498
-27,673
-5% -$504K ﹤0.01% 1958
2019
Q2
$13.7M Buy
559,171
+84,683
+18% +$2.08M ﹤0.01% 1782
2019
Q1
$4.51M Sell
474,488
-3,077
-0.6% -$29.3K ﹤0.01% 2378
2018
Q4
$4.23M Buy
477,565
+122,731
+35% +$1.09M ﹤0.01% 2395
2018
Q3
$3.99M Sell
354,834
-784
-0.2% -$8.82K ﹤0.01% 2507
2018
Q2
$4.55M Sell
355,618
-72,591
-17% -$929K ﹤0.01% 2444
2018
Q1
$7.24M Buy
428,209
+106,859
+33% +$1.81M ﹤0.01% 2157
2017
Q4
$2.57M Buy
321,350
+59,658
+23% +$477K ﹤0.01% 2703
2017
Q3
$2.03M Buy
261,692
+17,338
+7% +$134K ﹤0.01% 2830
2017
Q2
$1.8M Buy
244,354
+20,439
+9% +$150K ﹤0.01% 2910
2017
Q1
$1.67M Buy
223,915
+692
+0.3% +$5.16K ﹤0.01% 2959
2016
Q4
$1.55M Buy
223,223
+31,968
+17% +$222K ﹤0.01% 3013
2016
Q3
$1.57M Buy
191,255
+7,624
+4% +$62.7K ﹤0.01% 2913
2016
Q2
$1.49M Buy
183,631
+5,001
+3% +$40.5K ﹤0.01% 2885
2016
Q1
$907K Sell
178,630
-13,305
-7% -$67.6K ﹤0.01% 3125
2015
Q4
$1.48M Buy
191,935
+12,331
+7% +$95.2K ﹤0.01% 2887
2015
Q3
$1.03M Sell
179,604
-22,140
-11% -$127K ﹤0.01% 3146
2015
Q2
$1.85M Buy
+201,744
New +$1.85M ﹤0.01% 2972